| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/24/2013 | CN103068797A Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/24/2013 | CN103059033A New method for preparing formyl-porphyrins |
| 04/24/2013 | CN103059006A Chrysin-1,2,3-triazole compound having antibacterial activity, and its preparation method |
| 04/24/2013 | CN103059005A Chrysin amide derivative and medical application thereof |
| 04/24/2013 | CN103059004A Method of preparing 1-[Alpha-(2, 4-difluorophenyl)-2, 3-glycidyl]-1H-1, 2, 4-triazole |
| 04/24/2013 | CN103059002A Pyrimidine derivative with Aurora kinase inhibitory activity and preparation method and application thereof |
| 04/24/2013 | CN103058995A Quinazolinyl piperazine derivative and purpose thereof |
| 04/24/2013 | CN103058987A Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound |
| 04/24/2013 | CN103058972A Phenyl C-glucoside derivatives containing cyclohexane structure as well as preparation method and application thereof |
| 04/24/2013 | CN103058940A 1-substituted-4-bromo-2H-1,2,3-triazole derivative and preparation method thereof |
| 04/24/2013 | CN103058935A Pyrimidine compound as well as preparation method and use for same |
| 04/24/2013 | CN101522644B Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 04/23/2013 | US8426590 Process for the preparation of doxazosin and salts thereof |
| 04/23/2013 | US8426586 Using a acyl bromine compound; activation with phosphonacetic acid |
| 04/23/2013 | US8426444 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 04/23/2013 | US8426424 Certain substituted amides, method of making, and method of use thereof |
| 04/23/2013 | US8426420 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists |
| 04/23/2013 | CA2634168C Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 04/23/2013 | CA2555712C Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein |
| 04/23/2013 | CA2552419C Azadecalin glucocorticoid receptor modulators |
| 04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
| 04/18/2013 | WO2013056034A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013056003A2 Catechol diethers as potent anti-hiv agents |
| 04/18/2013 | WO2013054822A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | WO2013054351A1 Heterocyclic compounds |
| 04/18/2013 | WO2013054338A1 2-thio-imidazole derivatives as tgr5 modulators |
| 04/18/2013 | WO2013054302A1 Method for preparing triaryl(heteroaryl)bismuths, and uses thereof for the synthesis of aromatic or heteroaromatic derivatives |
| 04/18/2013 | WO2013053725A1 2-oxo-piperidinyl derivatives |
| 04/18/2013 | WO2013053422A1 Benzodioxepin-3-one compounds as dyes or as fluorescent emitters |
| 04/18/2013 | WO2013053206A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof |
| 04/18/2013 | WO2013053051A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | WO2013027196A9 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies |
| 04/18/2013 | US20130096303 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 04/18/2013 | US20130096145 Use of 1H-quinazoline-2,4-diones |
| 04/18/2013 | US20130096129 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096101 Inhibitors of hcv ns5a |
| 04/18/2013 | US20130096084 Novel heterocyclic compounds as erk inhbitors |
| 04/18/2013 | US20130096005 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
| 04/18/2013 | US20130095140 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 04/18/2013 | US20130095057 Compounds for the treatment of clostridium difficile-associated disease |
| 04/18/2013 | US20130095035 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
| 04/18/2013 | US20130092905 Material for organic electroluminescence element, and organic electroluminescence element using same |
| 04/18/2013 | CA2851087A1 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | CA2850394A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | CA2849385A1 2-oxo-piperidinyl derivatives |
| 04/17/2013 | EP2581449A2 Novel genes related to glutaminyl cyclase |
| 04/17/2013 | EP2581372A1 Cyanoquinoline derivatives |
| 04/17/2013 | EP2581366A1 Renin Inhibitors |
| 04/17/2013 | EP2581365A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/17/2013 | EP2580210A2 Estrogen receptor modulators and uses thereof |
| 04/17/2013 | CN103044409A Puerarin derivative or pharmaceutically acceptable salt and application thereof |
| 04/17/2013 | CN103044408A Itraconazole applied to treatment of malignant tumor or salt thereof and composition thereof |
| 04/17/2013 | CN103044407A Preparation method of olmesartan ester |
| 04/17/2013 | CN103044406A Coumarin derivative and preparation method and application in detecting cyanide ion |
| 04/17/2013 | CN103040831A Application of multi-substituted piperazinyl pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040826A Preparation and medical application of substituted pyranone compound |
| 04/17/2013 | CN103040825A Application of piperidyl-containing pyranone compound in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN102249879B 1,2-diketone derivant and preparation method thereof |
| 04/17/2013 | CN102181171B Iso-indigo derivative and applications of the iso-indigo derivative |
| 04/17/2013 | CN101973935B Preparation method and application of N-substituted-3,5-dibenzal piperidine-4-one |
| 04/17/2013 | CN101747323B Method for preparing alfuzosin hydrochloride |
| 04/17/2013 | CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/17/2013 | CN101389622B Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 04/17/2013 | CN101006092B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatment agent using the same |
| 04/16/2013 | US8420661 Arylethynyl derivatives |
| 04/16/2013 | US8420638 Triheterocyclic compounds and compositions thereof |
| 04/16/2013 | US8420636 Pyrrolidinyl-alkyl-amide derivatives, their preparation, and their therapeutic application as CCR3 receptor ligands |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420354 Methods to manufacture 1,3-dioxolane nucleosides |
| 04/16/2013 | US8420145 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 04/16/2013 | CA2576531C 1,5-diphenylpyrazoles |
| 04/16/2013 | CA2484512C Treatment of cataracts and other ophthalmic diseases |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013050438A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. |
| 04/11/2013 | WO2013050421A1 Herbicidal pyridazinone derivatives |
| 04/11/2013 | WO2013003812A3 Analyte detection using near-infrared fluorophores |
| 04/11/2013 | WO2012178105A3 Laminate comprising curable epoxy film layer comprising a di-isoimide and process for preparing same |
| 04/11/2013 | US20130090353 Noxious arthropod control composition and heterocyclic compound |
| 04/11/2013 | US20130090352 Tetrahydroquinoline amide m1 receptor positive allosteric modulators |
| 04/11/2013 | US20130090351 Analogues for the treatment or prevention of flavivirus infections |
| 04/11/2013 | US20130090346 Use of 1H-quinazoline-2,4-diones |
| 04/11/2013 | US20130090342 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/11/2013 | US20130090338 New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 04/11/2013 | US20130087776 Compound for organic photoelectric device and organic photoelectric device including the same |
| 04/11/2013 | US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/11/2013 | CA2851082A1 1,3-substituted azetidine pde10 inhibitors |
| 04/11/2013 | CA2851037A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases |
| 04/11/2013 | CA2850013A1 Herbicidal pyridazinone derivatives |
| 04/10/2013 | EP2578589A1 Oxygen-containing heterocyclic fused naphthopyrans having photochromic properties |
| 04/10/2013 | EP2578573A1 Fused imidazole derivative |
| 04/10/2013 | EP2578571A1 Isoquinoline modulators of ATP-binding cassette transporters |
| 04/10/2013 | EP2576638A2 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| 04/10/2013 | EP2576542A1 Ccr2 receptor antagonists |
| 04/10/2013 | EP2576538A1 New ccr2 antagonists |
| 04/10/2013 | EP2576511A1 Spiroheterocyclic pyrrolidine derivatives based pesticides |
| 04/10/2013 | EP2576509A1 Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies |
| 04/10/2013 | EP2576507A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/10/2013 | EP2575968A1 Compounds for the treatment of clostridium difficile associated disease |